Title:
PROCESS FOR PREPARING TANNATE TABLET CAPSULE OR OTHER SOLID DOSAGE FORMS
Document Type and Number:
WIPO Patent Application WO2004032826
Kind Code:
A3
Abstract:
An active pharmaceutical ingredient is combined with tannic acid to form a tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or purification is then blended with pharmaceutically acceptable excipients to form a granulate which is processed into a tablet or capsule to generate a therapeutic dosage form.
Inventors:
KIEL JEFFREY S
THOMAS GREG H
MANI NARASIMHAN
THOMAS GREG H
MANI NARASIMHAN
Application Number:
PCT/US2003/010918
Publication Date:
August 26, 2004
Filing Date:
April 09, 2003
Export Citation:
Assignee:
KIEL LAB INC (US)
International Classes:
A61K9/20; A61K9/26; A61K9/48; A61K31/7024; A61K45/06; C07H5/06; (IPC1-7): A61K9/14; A61K9/20; A61K9/26; A61K9/48
Foreign References:
| US6455727B1 | 2002-09-24 | |||
| US20030060422A1 | 2003-03-27 | |||
| US20030077321A1 | 2003-04-24 |
Other References:
See also references of EP 1622586A4
Download PDF:
Previous Patent: USE OF 2,3 ALKYLCARBONYLOXYBENZOIC ACIDS IN THE TREATMENT OF ANTHRAX
Next Patent: HEPATITIS C VIRUS INHIBITORS
Next Patent: HEPATITIS C VIRUS INHIBITORS